January 24, 2023
The annual Szent-Györgyi Prize for Progress in Cancer Research, sponsored by the National Foundation for Cancer Research (NFCR), is open now through February 28, 2023! The prize is a symbol of NFCR’s enduring commitment to uphold Dr. Szent-Györgyi’s vision of curing cancer through innovation and collaboration.
December 19, 2022
Led by Jessica Thaxton, PhD, MsCR, UNC School of Medicine scientists and colleagues found that targeting key proteins that control the T cell response to stress could help researchers develop more potent cancer immunotherapies.
May 4, 2022
UNC Children's renamed its hematology/oncology clinic The Reelin' for Research Pediatric Hematology Oncology Clinic in honor of the organization that donated $800,000 this week and more than $5 million since 2009, all to fund cancer research at UNC Children's.
April 12, 2022
UNC Lineberger’s Blossom Damania, PhD, and Dirk Dittmer, PhD, are each 2021 recipients of the Hyman L. Battle Distinguished Cancer Research Award, and will be honored at a reception in June 2022 for their individual high impact research accomplishments that have advanced the field of tumor virology, their service to the UNC School of Medicine and university …
February 3, 2020
The National Cancer Institute has named Satish Gopal, MD, MPH, director of the NCI Center for Global Health. He began this his new role February 3, 2020.
December 6, 2019
In the time it takes for an Amazon Prime delivery to arrive, cells damaged by chemotherapy can almost completely fix their most important DNA. That is the case in the livers of mice at least, according to a new study from UNC School of medicine researchers.
November 21, 2019
UNC Lineberger’s Jen Jen Yeh, MD, and Naim Rashid, PhD, reported findings on how two subtypes of pancreatic cancer respond to treatments differently. Importantly, they found that one subtype of the disease showed poor responses to common therapies, and also had worse survival rates.
November 7, 2019
The Innovator Awards recognize Association of Community Cancer Center member programs for their ingenuity and pioneering achievements in oncology. Innovations advance the goals of improving access, quality, and value in cancer care delivery.
October 9, 2019
Emily Harrison, PhD, a postdoc at the UNC Lineberger Comprehensive Cancer Center, was awarded $150,000 for research focused on inhibiting the mechanisms of lung cancer metastasis.
June 27, 2019
Kate Westmoreland, MD, has been amazed and excited by a surge of support for her work to improve treatment for adolescents and young adults with Burkitt lymphoma in Malawi, a country in Sub-Saharan Africa where this type of blood cancer is more common and deadly than in the United States.
April 18, 2019
Four UNC Lineberger researchers – Leaf Huang, Alexander Kabanov, Andrew Wang, and Jenny Ting – presented strategies for using tiny particles to boost cancer treatment as part of a National Cancer Institute site visit.
January 3, 2019
UNC Lineberger’s Joshua Zeidner, MD, reported preliminary data at the 60th American Society of Hematology Annual Meeting from a phase II clinical trial for administering a high-dose of the chemotherapy treatment cytarabine followed by an immune checkpoint inhibitor, pembrolizumab, in patients with acute myeloid leukemia that had relapsed or no longer responded to other treatment.